These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 604273)

  • 1. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
    Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
    Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 5. [HBsAg and anti-HBs in thalassemia non-transfused patients (and in their relatives)].
    Tannoia N; Putignano A; Cenci I; Colasuonno G; Dimonte D; Petrozzi L; Pastore G
    Boll Ist Sieroter Milan; 1978 May; 57(2):208-11. PubMed ID: 728269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic relationships of Australia antigen.
    London WT
    Vox Sang; 1973; 24():Suppl:1-7. PubMed ID: 4124190
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance after two years of HBsAg and HBsAb in multiply transfused thalassemic patients and in their relatives in Sardinia.
    Scalise G; Cuccuru G; Stangoni A; Mela G; Cutillo S; Dore A; Gioannini P
    Panminerva Med; 1979; 21(1):7-10. PubMed ID: 492747
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
    Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody against hepatitis associated antigen (H.A.A.) in children with thalassemia and the risk of posttransfusion hepatitis.
    Pongpipat D; Suvatte V; Ratanawong A
    J Med Assoc Thai; 1973 Jun; 56(6):341-6. PubMed ID: 4784773
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of haemotherapy in thalassaemias (20 years of Indian experience).
    Jolly JG; Agnihotri SK; Choudhury N; Gupta D
    J Indian Med Assoc; 1992 Jan; 90(1):7-9. PubMed ID: 1593146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of anti-Au antibodies in polytransfused thalassemic patients].
    Moscatelli P; Burlando L; Sciarratta GV
    Pathologica; 1971; 63(925):275-9. PubMed ID: 5155559
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671
    [No Abstract]   [Full Text] [Related]  

  • 17. Australia antigen and antibodies: a study in Italian patients.
    Vierucci A; Ragazzini F
    Folia Allergol (Roma); 1970; 17(6):524-37. PubMed ID: 4252721
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassaemia major.
    Lee WS; Teh CM; Chan LL
    J Paediatr Child Health; 2005; 41(5-6):265-8. PubMed ID: 15953326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc.
    Hopkins R; Kane E; Robertson AE; Haase G
    Med Lab Sci; 1982 Jan; 39(1):61-2. PubMed ID: 7098783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.